Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020–Sep 2020; Sep 2020–May 2021) in the Veneto Oncology Network: The ROVID study-Reference-Cited by-同舟云学术

Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020–Sep 2020; Sep 2020–May 2021) in the Veneto Oncology Network: The ROVID study

Published:2022-05 Issue: Volume:167 Page:81-91
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Dieci Maria V.^ORCID,Azzarello Giuseppe^ORCID,Zagonel Vittorina,Bassan Franco^ORCID,Gori Stefania^ORCID,Aprile Giuseppe,Chiarion-Sileni Vanna,Lonardi Sara^ORCID,Oliani Cristina,Zaninelli Marta,Chiari Rita,Favaretto Adolfo^ORCID,Pavan Alberto^ORCID,Di Liso Elisabetta^ORCID,Mioranza Eleonora,Baldoni Alessandra,Bergamo Francesca,Maruzzo Marco^ORCID,Ziampiri Stamatia,Inno Alessandro^ORCID,Graziani Filomena^ORCID,Sinigaglia Giusy,Celestino Michele,Conte Pierfranco^ORCID,Guarneri Valentina^ORCID

Funder

AstraZeneca

Servier

Celgene

Bayer

Ipsen

Fondazione Cassa di Risparmio di Padova e Rovigo

GlaxoSmithKline

Janssen Pharmaceuticals

Roche

Merck KGaA

Pfizer